Cortical neurochemistry in euthymic patients with bipolar i disorder

World Journal of Biological Psychiatry

Volumn 10, Issue 4, 2009, Pages 285-294

  Scherk, Harald ^a   Backens, Martin ^b   Schneider Axmann, Thomas ^a   Usher, Juliana ^a   Kemmer, Claudia ^b   Reith, Wolfgang ^b   Falkai, Peter ^a   Gruber, Oliver ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Anterior cingulate cortex; Bipolar disorder; Magnetic resonance spectroscopy; N acetyl aspartate; Prefrontal cortex

Indexed keywords

CHOLINE; CREATINE; INOSITOL; LITHIUM; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BIPOLAR I DISORDER; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LITHIUM BLOOD LEVEL; MALE; NEUROCHEMISTRY; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AFFECT; ANTIMANIC AGENTS; ASPARTIC ACID; BIPOLAR DISORDER; CHOLINE; CREATINE; DOMINANCE, CEREBRAL; FEMALE; GYRUS CINGULI; HUMANS; INOSITOL; LITHIUM CARBONATE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PREFRONTAL CORTEX; REFERENCE VALUES; SEX FACTORS; YOUNG ADULT;

EID: 70449768330     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970701472086     Document Type: Article

References (30)

1. Bertolino A, Frye M, Callicott JH, et al. 2003. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 53:906-913.
2. Bertolino A, Callicott JH, Elman I, et al. 1998. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 43:641-648. (Pubitemid 28222384)
3. Brambilla P, Stanley JA, Nicoletti MA, et al. 2005. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord 86:61-67. (Pubitemid 40487960)
4. Brambilla P, Stanley JA, Sassi RB, et al. 2004. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 29:1918-1924.
5. Block W, Bayer TA, Tepest R, et al. 2000. Decreased frontal lobe ratio of AT-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study. Neurosci Lett 289:147-151.
6. Burtscher IM, Holtas S. 2001. Proton MR spectroscopy in clinical routine. J Magn Reson Imaging 13:560-567.
7. Cecil KM, DelBello MP, Morey R, Strakowski SM. 2002. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 4:357-365.
8. Cecil KM, Lenkinski RE, Gur RE, Gur RC. 1999. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology 20:131-140.
9. Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK. 2000. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 75:1729-1734.
10. Dager SR, Friedman SD, Parow A, et al. 2004. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 61:450-458
11. Duvernoy HM. 1999. The human brain. Surface, three-dimensional sectional anatomy and MRI and blood supply. Wien: Springer.
12. Hamakawa H, Kato T, Shioiri T, Inubushi T, Kato N. 1999. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychol Med 29:639-644.
13. Jessen F, Scherk H, Traber F, et al. 2006. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia. Schizophr Res 87:81-88.
14. Manji HK, Moore GJ, Chen G. 2000. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry 48:740-754.
15. McDonald C, Zanelli J, Rabe-Hesketh S, et al. 2004. Metaanalysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry 56:411-417
16. Moore CM, Breeze JL, Gruber SA, et al. 2000. Choline, myoinositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2:207-216.
17. Moore GJ, Bebchuk JM, Parrish JK, et al. 1999. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 156:1902-1908.
18. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. 2000a. Lithium-induced increase in human brain grey matter. Lancet 356:1441-1442.
19. Moore GJ, Bebchuk JM, Hasanat K, et al. 2000b. Lithium increases AT-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 48:1-8.
20. Ohrmann P, Siegmund A, Suslow T, et al. 2007. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-näive and chronic medicated schizophrenic patients: A proton magnetic resonance spectroscopy study. J Psychiatr Res 41:625-634.
21. Phillips ML, Drevets WC, Rauch SL, Lane R. 2003. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 54:515-528.
22. Sassi RB, Nicoletti M, Brambilla P, et al. 2002. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett 329:243-245.
23. Scherk H, Reith W, Falkai P. 2004. Changes in brain structure in bipolar affective disorders. Der Nervenarzt 75:861-872. (Pubitemid 39312511)
24. Silverstone PH, McGrath BM, Kim H. 2005. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disord 7:1-10.
25. Soares JC, Mann JJ. 1997. The anatomy of mood disorders-review of structural neuroimaging studies. Biol Psychiatry 41:86-106.
26. Steen RG, Hamer RM, Lieberman JA. 2005. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and metaanalysis. Neuropsychopharmacology 30:1949-1962.
27. Talairach P. Tournoux. 1998. Coplanar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers.
28. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. 2000. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 47:475-481.
29. Wittchen HU, Zaudig M, Fydrich T 1997. Strukturiertes klinisches Interview fur DSM-IV Achse I und II. Gottingen: Hogrefe.
30. Wobrock T, Scherk H, Falkai P. 2005. Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations. Radiologe 45:124-30, 132-136.